Fluphenazine levels during maintenance treatment of recent-onset schizophrenia: relation to side effects, psychosocial function and depression (original) (raw)

Fluphenazine decanoate in acute and maintenance therapy of schizophrenia

Massimo Carlo Mauri

Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1987

View PDFchevron_right

Fluphenazine decanoate dose and severity of depression in patients with post-psychotic depression

Samuel Siris

Schizophrenia Research, 1988

View PDFchevron_right

Outpatient Maintenance of Chronic Schizophrenic Patients with Long-acting Fluphenazine: Double-blind Placebo

Steven Hirsch

BMJ, 1973

View PDFchevron_right

Fluphenazine plasma level monitoring for patients receiving fluphenazine decanoate

Jim Mintz

Schizophrenia Research, 2002

View PDFchevron_right

Flupwenazine Decanoate in Acute and ~Ainten~Ce Therapy of Schizop~K~Nia

Massimo Carlo Mauri

1987

View PDFchevron_right

Depressive and extrapyramidal symptoms and clinical effects: a trial of fluphenazine versus flupenthixol in maintenance of schizophrenic out- patients

Steven Hirsch

The British Journal of Psychiatry, 1979

View PDFchevron_right

Treatment of acute schizophrenia with ultra-high-dose fluphenazine: A failure at shortening time on a crisis-intervention unit

Donald Klein

Comprehensive Psychiatry, 1975

View PDFchevron_right

Oral fluphenazine versus placebo for schizophrenia: a Cochrane systematic review of 40 years of randomised controlled trials

Muhammad Almerie

Revista Colombiana De Psiquiatria, 2007

View PDFchevron_right

Fluphenazine decanoate: a clinical problem?

Rich Lewine

American Journal of Psychiatry, 1989

View PDFchevron_right

Double-blind, randomized comparison of olanzapine versus fluphenazine in the long-term treatment of schizophrenia

Ljubomir Hotujac

Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2004

View PDFchevron_right

Depot fluphenazine and flupenthixol in the treatment of stabilized schizophrenics. A double-blind comparative trial

Carlos Chacon

Comprehensive Psychiatry, 1980

View PDFchevron_right

Fluphenazine decanoate (timing of administration) for people with schizophrenia

Aisha Aljojo

Cochrane Database of Systematic Reviews, 2017

View PDFchevron_right

Efficacy of flupentixol and risperidone in chronic schizophrenia with predominantly negative symptoms

Stephan Ruhrmann

Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2007

View PDFchevron_right

Comparative bioavailability of two tablet formulations of fluphenazine dihydrochloride in drug-free psychiatric patients

Mohammad Al-Yamani

Journal of Pharmaceutical Sciences, 1990

View PDFchevron_right

Fluphenazine decanoate (depot) and enanthate for schizophrenia

Nicola Maayan

The Cochrane database of systematic reviews, 2015

View PDFchevron_right

Comparative effectiveness of fluphenazine decanoate injections every 2 weeks versus every 6 weeks

Ann Summerfelt

The American journal of psychiatry, 1999

View PDFchevron_right

Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities

LESLIE CITROME

Schizophrenia Research, 2010

View PDFchevron_right

Risperidone, Quetiapine, and Fluphenazine in the Treatment of Patients With Therapy-Refractory Schizophrenia

Marie Mackowick -MDH-

Clinical Neuropharmacology, 2005

View PDFchevron_right

Fluphenazine decanoate (timing of administration) for people with schizophrenia (protocol)

Nawras Alhalabi, Aisha Aljojo, Tawfik Rajab

Fluphenazine decanoate (timing of administration) for people with schizophrenia (protocol), 2017

View PDFchevron_right

Comparison Of Effect Of Addition Of Fluvoxamine Or Risperidone To Clozapine In Chronic Partially Responsive Schizophrenic Patients On Clinical Response, QTc interval And Lipid profile

Praveer Waradkar

International Journal of Pharmacological Research, 2016

View PDFchevron_right

Depression in schizophrenia: Comparison of first- and second-generation antipsychotic drugs

Massimo Carlo Mauri

Schizophrenia Research, 2008

View PDFchevron_right

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

Karla Davila Soler

… England Journal of …, 2005

View PDFchevron_right

Impact of Second-Generation Antipsychotics and Perphenazine on Depressive Symptoms in a Randomized Trial of Treatment for Chronic Schizophrenia

Somaia Mohamed

The Journal of Clinical Psychiatry, 2010

View PDFchevron_right

Comparison of Polypharmacy in Schizophrenia and Other Psychotic Disorders in Outpatient and Inpatient Treatment Periods: A Naturalistic One Year Follow-up Study

hasan karadag

View PDFchevron_right

Clinical and Biologic Response to Clozapine in Patients With Schizophrenia Crossover Comparison With Fluphenazine

P. Konicki

View PDFchevron_right

Time-Dependent Clearance Decrements of Fluvoxamine in Depressed Inpatients

Walter van den Broek

Journal of Clinical Psychopharmacology, 2007

View PDFchevron_right

Depot fluphenazine decanoate and enanthate for schizophrenia (Review

Maurice Eisenbruch

View PDFchevron_right

The effects of olanzapine and fluphenazine on plasma cortisol, prolactin and muscle rigidity in schizophrenic patients: a double blind study

N. Pivac

Progress in Neuro- …, 2007

View PDFchevron_right